The Trump administration launched its new TrumpRx prescription drug listing site late Thursday, part of a push by President Trump to offer lower direct-to-consumer drug prices.
The president struck deals last year with more than a dozen drugmakers to list some of their medication on TrumpRx at steep discounts from list prices, with megacompanies like Pfizer and Novo Nordisk — known for weight loss and diabetes drugs Ozempic and Wegovy — signing on.
The site lists dozens of prescription drugs at reduced rates. For example, a four-week supply of Wegovy injection pens is listed at $199 for the first two months and $349 after that, well below the list price of $1,349.02.
The site does not sell drugs directly — instead, users are prompted to print out a gold-embossed coupon that it says can be used at pharmacies.
In a White House event Thursday evening, Mr. Trump called it “one of the most transformative health care initiatives of all time.”
It’s not clear how much of an impact TrumpRx will have on the prices most Americans pay for prescription drugs. The site lists direct-to-consumer prices, but most people pay for their medication through insurance rather than out-of-pocket. The site notes: “If you have insurance, check your co-pay first—it may be even lower.”
This is a breaking story; it will be updated.